Plant Uptake and Metabolism of 2,4-Dibromophenol in Carrot: In Vitro Enzymatic Direct Conjugation | Journal of Agricultural and Food Chemistry
Structure-activity relationships of fluorene compounds inhibiting HCV variants - ScienceDirect
Evolution of efficacious pangenotypic hepatitis C virus therapies - Ashraf - 2019 - Medicinal Research Reviews - Wiley Online Library
Velpatasvir | C49H54N8O8 - PubChem
PathWhiz
Velpatasvir - an overview | ScienceDirect Topics
Sofosbuvir: Arrival of a paradigm shift in the management of hepatitis C in India Singh K, Kamat S K, Shukla A - J Med Soc
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update | SpringerLink
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant | ACS Omega
Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology
Sofosbuvir-Velpatasvir Epclusa - Treatment - Hepatitis C Online
Recent advances in managing chronic HCV... | F1000Research
Viruses | Free Full-Text | Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
Epclusa (sofosbuvir + velpatasvir)
Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents: Challenges in Developing Countries - ScienceDirect
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Sofosbuvir - Wikipedia
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
New perspectives for preventing hepatitis C virus liver graft infection - The Lancet Infectious Diseases
Frontiers | Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
Advances in Treatment of Hepatitis C | IntechOpen
